Individualizing Oral SERD Therapy

CE / CME

Individualizing Therapy for Metastatic Breast Cancer: Oral SERD Therapy

Physician Assistants/Physician Associates: 0.25 AAPA Category 1 CME credit

Nurses: 0.25 Nursing contact hour

Pharmacists: 0.25 contact hour (0.025 CEUs)

Physicians: maximum of 0.25 AMA PRA Category 1 Credit

Released: May 28, 2024

Expiration: May 27, 2025

La-Urshalar B. Brock
La-Urshalar B. Brock, FNP-BC, CNM, RNFA
Allison Butts
Allison Butts, PharmD, BCOP
Marla Lipsyc-Sharf
Marla Lipsyc-Sharf, MD

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

For patients with breast cancer with disease progression on a CDK4/6 inhibitor plus endocrine therapy, which mutation would make them a candidate for an approved oral selective estrogen receptor degrader (SERD)?